Orphapacket:
  AverageAgeOfOnsets:
  - AverageAgeOfOnset:
      value: Childhood
  - AverageAgeOfOnset:
      value: Infancy
  - AverageAgeOfOnset:
      value: Neonatal
  Childs:
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) in
          ExternalReferences:
          - Reference: '3551'
            Source: HGNC
          - Reference: '300746'
            Source: OMIM
          Label: coagulation factor IX
          Symbol: F9
      Label: Severe hemophilia B
      ORPHAcode: '169793'
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) in
          ExternalReferences:
          - Reference: '3551'
            Source: HGNC
          - Reference: '300746'
            Source: OMIM
          Label: coagulation factor IX
          Symbol: F9
      Label: Moderate hemophilia B
      ORPHAcode: '169796'
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) in
          ExternalReferences:
          - Reference: '3551'
            Source: HGNC
          - Reference: '300746'
            Source: OMIM
          Label: coagulation factor IX
          Symbol: F9
      Label: Mild hemophilia B
      ORPHAcode: '169799'
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) in
          ExternalReferences:
          - Reference: '3551'
            Source: HGNC
          - Reference: '300746'
            Source: OMIM
          Label: coagulation factor IX
          Symbol: F9
      Label: Bleeding disorder in hemophilia B carriers
      ORPHAcode: '177929'
  - Child:
      Genes: no data
      Label: Hemophilia B Leyden
      ORPHAcode: '617930'
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
    Reference: '306900'
    Source: OMIM
  Label: Hemophilia B
  ORPHAcode: '98879'
  ORPHApacketId: '98879'
  PURL: http://www.orpha.net/ORDO/Orphanet_98879
  Parents:
  - Parent:
    - Label: Hemophilia
      ORPHAcode: '448'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000790
      HPOTerm: Hematuria
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001058
      HPOTerm: Poor wound healing
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002170
      HPOTerm: Intracranial hemorrhage
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003010
      HPOTerm: Prolonged bleeding time
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003645
      HPOTerm: Prolonged partial thromboplastin time
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0004406
      HPOTerm: Spontaneous, recurrent epistaxis
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0004846
      HPOTerm: Prolonged bleeding after surgery
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0005261
      HPOTerm: Joint hemorrhage
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0006298
      HPOTerm: Prolonged bleeding after dental extraction
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0011858
      HPOTerm: Reduced factor IX activity
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0012233
      HPOTerm: Intramuscular hematoma
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0012541
      HPOTerm: Cephalohematoma
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0040232
      HPOTerm: Delayed onset bleeding
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0400008
      HPOTerm: Menometrorrhagia
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]_European Medicines Agency 2018[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Albania
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Algeria
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Argentina
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Armenia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Austria
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Azerbaijan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Bangladesh
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Belarus
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Belgium
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Belize
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Bolivia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Bosnia and Herzegovina
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Brazil
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Bulgaria
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Chile
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Colombia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Costa rica
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Croatia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Cuba
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Cyprus
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Czech Republic
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Denmark
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Dominican Republic
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Ecuador
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Egypt
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: El Salvador
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Eritrea
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Estonia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Georgia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Guatemala
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Honduras
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Hungary
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Iceland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: India
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Indonesia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Iran, Islamic Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Iraq
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Korea, Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Latvia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Lithuania
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Luxembourg
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: North Macedonia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Malaysia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Malta
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Mexico
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Moldova, Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Mongolia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Morocco
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Nepal
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: New Zealand
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Nigeria
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Pakistan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Palestinian Territory, occupied
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Peru
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Philippines
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Portugal
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Qatar
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Russian Federation
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Saudi Arabia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Senegal
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Serbia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Sierra leone
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Singapore
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Israel
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Jamaica
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Jordan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Kenya
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Lebanon
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Nicaragua
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Panama
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Paraguay
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Romania
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Slovakia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Slovenia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: South Africa
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Sri Lanka
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Sudan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Sweden
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Switzerland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Thailand
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Togo
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Tunisia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Turkey
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Ukraine
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Uruguay
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Uzbekistan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Venezuela
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Viet Nam
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Zimbabwe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21649801[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 20301668[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: France
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: https://www.francecoag.org/SiteWebPublic/public/stats/stats_page.jsp?stat3=on
      ValMoy: no data
  Synonyms:
  - Synonym: Christmas disease
  - Synonym: Congenital F9 deficiency
  - Synonym: Congenital factor IX deficiency
  TextSection:
    Contents: A rare hematological disorder characterized by spontaneous or prolonged
      hemorrhages due to factor IX deficiency.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: X-linked recessive
  copyright: Orphanet (c) 2024
  creationDate: '2024-12-03 10:13:55'
  version: 1.3.29 / 4.1.7 [2023-08-02] (orientdb version)
